Neuronetics (STIM) Net Cash Flow Growth (3y) (2020 - 2026)

Neuronetics (STIM) Net Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 183.54 Bn 176.25 Bn 6.27 Bn -32.51%
2 Stryker 128.93 Bn 126.05 Bn 3.81 Bn -87.87%
3 Medtronic 108.84 Bn 99.62 Bn 6.41 Bn 31.32%
4 Boston Scientific 68.42 Bn 66.96 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 47.32 Bn 43.65 Bn 1.29 Bn -87.88%
6 GE HealthCare Technologies 28.46 Bn 26.18 Bn 1.98 Bn -65.12%
7 Dexcom 28.46 Bn 27.34 Bn 750.30 Mn 129.29%
8 Smith & Nephew 26.97 Bn 26.40 Bn - -
9 Koninklijke Philips 25.55 Bn 22.42 Bn 2.07 Bn -48.90%
10 Neuronetics 123.17 Mn 117.17 Mn 16.15 Mn -0.61%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.61%
Dec 31, 2025 53.16%
Sep 30, 2025 83.11%
Jun 30, 2025 27.61%
Mar 31, 2025 28.72%
Dec 31, 2024 35.76%
Sep 30, 2024 30.86%
Jun 30, 2024 2.53%
Mar 31, 2024 -29.37%
Dec 31, 2023 149.46%
Sep 30, 2023 -45.33%
Jun 30, 2023 0.39%
Mar 31, 2023 -7.29%
Dec 31, 2022 20.42%
Sep 30, 2022 33.52%
Jun 30, 2022 -15.07%
Mar 31, 2022 -16.39%
Dec 31, 2021 -34.61%
Sep 30, 2021 -29.61%
Jun 30, 2021 1.85%